- Home
- ARBEW vs BDTX Comparison
ARBEW vs BDTX Comparison
Compare ARBEW & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARBEW | BDTX |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | Israel | United States |
| Employees | 144 | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 220.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ARBEW | BDTX |
|---|---|---|
| Price | $0.14 | $2.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $10.60 |
| AVG Volume (30 Days) | 32.4K | ★ 1.6M |
| Earning Date | 03-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.38 |
| Revenue | $768,000.00 | ★ $70,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.93 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.13 | $1.20 |
| 52 Week High | $1.25 | $4.94 |
Technical Indicators
Market Signals| Indicator | ARBEW | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 36.96 | 29.41 |
| Support Level | $0.13 | $2.61 |
| Resistance Level | $0.24 | $2.84 |
| Average True Range (ATR) | 0.03 | 0.25 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 8.33 | 22.59 |
Price Performance
Historical ComparisonAbout ARBEW Arbe Robotics Ltd. Warrant
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.